Recruitment

Recruitment Status
Completed

Inclusion Criteria

Medication Possession Ratio (MPR) <80%
Diabetes and or history of CVD
CVS Caremark Beneficiary
...
Medication Possession Ratio (MPR) <80%
Diabetes and or history of CVD
CVS Caremark Beneficiary
LDL > or = 130 mg/dl - measured during screening
A prescription filled for statin medication within the last 12 months

Exclusion Criteria

Will not or cannot give consent
Currently participating in another clinical trial with related aims
History of active or progressive liver disease or abnormal liver function tests on baseline screening
...
Will not or cannot give consent
Currently participating in another clinical trial with related aims
History of active or progressive liver disease or abnormal liver function tests on baseline screening
Less than 18 years old
Co-morbidities likely to lead to death within a short-period
Contraindication to further statin use or have suffered side effects from statins, such as myopathy

Summary

Conditions
Diabetes
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Single (Investigator)
  • Primary Purpose: Other

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Inclusion Criteria

Medication Possession Ratio (MPR) <80%
Diabetes and or history of CVD
CVS Caremark Beneficiary
...
Medication Possession Ratio (MPR) <80%
Diabetes and or history of CVD
CVS Caremark Beneficiary
LDL > or = 130 mg/dl - measured during screening
A prescription filled for statin medication within the last 12 months

Exclusion Criteria

Will not or cannot give consent
Currently participating in another clinical trial with related aims
History of active or progressive liver disease or abnormal liver function tests on baseline screening
...
Will not or cannot give consent
Currently participating in another clinical trial with related aims
History of active or progressive liver disease or abnormal liver function tests on baseline screening
Less than 18 years old
Co-morbidities likely to lead to death within a short-period
Contraindication to further statin use or have suffered side effects from statins, such as myopathy

Tracking Information

NCT #
NCT02086539
Collaborators
  • Rutgers University
  • National Institute on Aging (NIA)
Investigators
  • Principal Investigator: Kevin G Volpp, MD, PhD University of Pennsylvania
  • Kevin G Volpp, MD, PhD University of Pennsylvania